Ursodeoxycholic acid as a novel disease-modifying treatment for Parkinson’s disease: protocol for a two-centre, randomised, double-blind, placebo-controlled trial, The 'UP' study

by Thomas Foltynie, Thomas Payne, Iain D Wilkinson, Ellen Buckley, Claudia Mazza, Matilde Sassani, Sarah Moll, Adriana Anton, Matthew Appleby, Seema Maru, Rosie Taylor, Alisdair McNeill, N Hoggard, Thomas Jenkins, O Bandmann
Published 2020-08-01